Vaxess Technologies Inc.
Boston, Massachusetts, United States
Purpose
to advance preclinical development of the measles rubella vaccine microarray patch combination product
Division
Global Development, Global Health
Date
November 2016
Region Served
GLOBAL
Committed amount
$3,539,874
Grant topic
Pneumonia & Pandemic Preparedness, Vaccine Delivery
Duration (months)
34
Grantee location
Boston, Massachusetts, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.